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In this work, the toxicological assesment of the organic phase resulted from the COSORB 
process was performed. For this purpose, an animal model was used to evaluate the effects of 
the organic phase on skin physiological parameters after topical application to SKH-1 hairless 
mice. The obtained results revealed that the constituents of the organic phase induce skin 
toxicity by disturbing the physiological skin parameters status, which represents the first signs 
of skin pathology. 
 
Introduction 
The COSORB process involves a selective elimination of carbon monoxide by means of 
complexation/decomplexation of CO on a specific catalyst, in an appropriate aromatic 
solvent. [1] By this process, it is possible to complexate and recover more then 99% of the 
CO content [2]. 
The calalyst is a bimetalic complex of MeI eIIXn type, where MeI is often Cu(I), and 
M II is Al(III), X being a halogen, such as chlorine. During the process, the catalyst is involved 
in several complexation/decomplexation processes, resulting finally in a partialy poisoned 
catalyst due to the accumulation of some sulfures and/or other secondary alkylation or 
polymerisation products. The disposal of the used catalyst involves several environmental 
risks, due to its high metal content, and the recovry and subsequent use of these metals 
presents a great deal of interest. Thus, several processes of Cu and toluene have been 
developped [3-8]. All of these technologies have advantages and disadvantages, and more or 
less specific shortcomings, their efficiency being strongly dependent by the type of 
compound. However, none of the technologies can remov  all of the compounds from 
wastewaters.  
Based on these considerations, it seems that the dev loppement of an unitary 
technology able to recover all of the usefull materi ls from the used catalyst should be of 
great interest. Moreover, the toxicological evaluation of all stages involved in such a 
technology will bring more added value to this technology.  
   
Experimental 
The analysis of the organic phase was carried-out by means of gas chromatography/ mass 
spectroscopy (GC/MS), using a Hewlett Packard Gaz Chromatograph HP 6890 associated 
with a Mass Spectrometer HP 5973. The GC column was of ZB-5MS type, and had a 
30m×0.25mm inner diameter and a film thickness of 0,25 µm. The stationary phase was a 
mixture of 95% dimethyl siloxane and 5% phenyl-aryilene. The column temperature program 
was of 6 o/ min, in the temperature range of  50-300°C. 





The animals used in the present study were SKH1 hairless male mice (12-14 weeks-
old) purchased from Charles River Laboratories, Budapest, Hungary. All experimental 
procedures were conducted in accordance with the Directive 2010/63/EU on the protection of 
animals used for scientific purposes. The experimental protocol was approved by the 
Committee for Ethics Research of the University for Medicine and Pharmacy of Timisoara, 
Romania. Animals were fed ad libitum and kept under standard conditions: constant 
temperature of 22.5 ± 2° C, humidity 55 ± 5% and a 12-h light/dark cycle. 
In order to accomplish the present study, the mice were divided in 2 groups (n=5/mice 
group): group 1 - control group – no interventions were applied; group 2 – the mice were 
treated with the organic phase solution (100µl) which was applied on the dorsal area twice a 
week for 5 weeks. 
For the evaluation of skin response to organic phase effect, we measured several 
physiological skin parameters (erythema and TEWL – transepidermal water loss) by the 
means of a non-invasive technique (mexametry and tewametry) using MPA5 System from 
Courage-Khazaka. 
 
Results and discussion 
In this work, the toxicological evaluation of the organic phase resulted from the COSORB 
process was carried-on, using an animal model. 
The content of the organic phase was evaluated by GC/MS and the results are 
illustrated in Table 1. The percentage composition of the organic phase reveal the presence of 
84,46 % toluene (RT = 1,9), 10,1% oxydation products of toluene (RT=21-23 derivatives of 
bis-(methyl-phenyl) ketone, RT= 28-32 derivatives of trimethyl tritil alcohol), 5,3% 
xylenes (RT = 3-4) and 0,1% benzene (RT = 1.3). 
 
  





Table 1. The content of the organic phase resulted from the COSORB process 
Nr.  Retention time (RT) Peak area Area % 
1 1,323 59577 0,081 
2 1,946 62040506 84,466 
3 2,632 196840 0,268 
4 2,832 256827 0,35 
5 3,021 1320320 1,798 
6 3,346 359668 0,49 
7 4,318 156802 0,213 
8 4,455 165834 0,226 
9 21,659 704812 0,96 
10 22,407 190586 0,259 
11 22,882 543778 0,74 
12 23,316 1284443 1,749 
13 23,665 124753 0,17 
14 28,146 146443 0,199 
15 28,734 392714 0,535 
16 29,317 393223 0,535 
17 29,872 141317 0,192 
18 30,083 354484 0,483 
19 30,729 1807869 2,461 
20 31,369 2215855 3,017 
21 31,992 593709 0,808 
 
As it can be seen from the results depicted in Table 1, toluene is the major constituent 
of the organic phase resulted from the COSORB process, and it is known that this volatile 
organic compound, affects the central nervous system, as well as the heart, but its noxious 
effects at skin level are not fully elucidated [9].  
 Further, the effects of this organic phase were inv stigated at skin level, after topical 
application on SKH1 mice, as described in Experimental part. The evaluation of these efects 
were carried out by means of non-invasive methods, e.g. tewametry and mexametry. The 
main reason for our choice was the fact that hairless mice represent a great tool for the 
evaluation of the changes that occur at cutaneous level, changes that can be associated with 
the application of a toxic or a new drug in the testing phase or after absorption of some 
substances that possess the capacity to modify skin parameters [10,11]. 
Moreover, Tewametry and mexametry are established non-invasive methods, used 
very frequently in the diagnostic of skin pathologies both in humans and in i  vivo 
experiments [12, 13]. 
One of the skin parameters measured in this experiment using a Mexameter probe was 
the erythema value.  
The topical application of the organic phase to the SKH1 mice led to relevant changes 
regarding the skin parameters evaluated. Our results howed that the application of the test 
solution induced a significant degree of erythema as compared with the control group (see 
Figure 1). 
 







Figure 1. Control group and organic phase group - topically pplied (data are expressed as 
differences ± SE). The units are arbitrary. 
 
An increase was also observed in the values measured fo  transepidermal water loss 
(TEWL) in the group treated with the test solution n comparison with the control group, as 
illustrated in Figure 2.  
TEWL value is considered an index for the estimation of the degree of injury of skin 
barrier and it measures the rate of skin water loss (it i  expressed in g/hm2) [14]. An increased 
value of TEWL indicates an injury or a skin pathology [15]. 
Our results showed that the TEWL values were higher in the group that was topically 




Figure 2. Transepidermal water loss (TEWL) evaluation: Contrl g oup and Organic phase 
group - topically applied (data are expressed as differences ± SE). The units are arbitrary. 







Our preliminary results indicate that the constituents of the organic phase induce skin toxicity 
by disturbing the physiological skin parameters status, which represents the first signs of skin 
pathology. Further studies are required in order to elucidate the mechanism involved. 
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